Biofrontera Inc. is a biopharmaceutical company that develops, manufactures, and commercializes pharmaceutical products for dermatological conditions, focusing on photodynamic therapy treatments for actinic keratosis, a common pre-cancerous skin condition. The company's primary revenue generators are Ameluz, a pharmaceutical product, and the BF-RhodoLED and RhodoLED XL lamp series used in treatment; these are sold directly to dermatology practices and healthcare groups through an in-house commercial team. The company operates by acquiring or licensing complementary products and intellectual property to expand its portfolio and leverage its existing customer relationships and infrastructure in the dermatology space.